Products ({{ products.totalElements }})
News & articles ({{ wpNewsAndArticles.total_posts }})
Blog entries ({{ wpBlogEntries.total_posts }})

{{ String(product.attributes.name) }} {{ String(product.attributes.productType) }} - NEW	{{ String(product.attributes.artNo) }}	{{ (String(product.attributes.sizeStr) != 'undefined') ? String(product.attributes.sizeStr) : '–' }}	Not available On Request {{ formatPrice(product.attributes.discountPrice.toString()) }} {{ formatPrice(product.attributes.price.toString()) }} {{ formatPrice(product.attributes.discountPrice.toString()) }} {{ formatPrice(product.attributes.price.toString()) }} Login for price

Full search results →

No products found

News {{ news.date \| formatDate }} #{{tag.name}}

No news & articles found

Full search results →

blog entry {{ blogEntry.date \| formatDate }}

No blog entries found

Full search results →

Tubastatin A

Chemicals & Biochemicals

Make a customized order

Article No

AG-CR1-3900-M010

Size

10 mg

Shipping Information

Article No

AG-CR1-3900-M010

Size

10 mg

Specifications

CAS No	1239262-52-2, 1252003-15-8
MW	335.4
Article No	AG-CR1-3900-M010
Country Availability	SE, FI, DK, NO, IS, EE, LV, LT
Description	Tubastatin A
Supplier	Adipogen Life Sciences
Format	Powder
Notes	Cell permeable potent and selective class IIb histone deacetylase 6 (HDAC6) inhibitor (IC50=15nM, >1000-fold selective against other HDACs and 60-fold for HDAC8). Neuroprotective. Effectively prevents neuronal cell death (by >95% at 10µM) upon oxidative stress induction by HCA and selectively induces cellular alpha-tubulin, but not histone H4, hyperacetylation (2.5 to 5µM) in primary rat cortical neuron cultures. Improves cognition in Alzheimer's disease transgenic mice. Exhibits cardioprotective and anticancer chemotherapeutic activities. Reduces tumor growth and cell proliferation and induces cell cycle arrest in G1. Inhibits TNFalpha (IC50=272nM) and IL-6 (IC50=712nM) in LPS-stimulated human THP-1 macrophages and displays anti-inflammatory activity in animal models. Antileishmanial. HDAC6 deacetylates tubulin, HSP90 and the core histones (H2A, H2B, H3, H4). Histone deacetylases act via the formation of large multiprotein complexes. HDAC6 plays an important role in microtubule-dependent cell motility, transcriptional regulation, degradation of misfolded proteins and cell cycle and is involved in autophagy, inflammation, cancer and neurodegeneration.\|Chemical. CAS: 1252003-15-8. Formula: C20H21N3O2. MW: 335.4. Cell permeable potent and selective class IIb histone deacetylase 6 (HDAC6) inhibitor (IC50=15nM, >1000-fold selective against other HDACs and 60-fold for HDAC8). Neuroprotective. Effectively prevents neuronal cell death (by >95% at 10µM) upon oxidative stress induction by HCA and selectively induces cellular alpha-tubulin, but not histone H4, hyperacetylation (2.5 to 5µM) in primary rat cortical neuron cultures. Improves cognition in Alzheimer's disease transgenic mice. Exhibits cardioprotective and anticancer chemotherapeutic activities. Reduces tumor growth and cell proliferation and induces cell cycle arrest in G1. Inhibits TNFalpha (IC50=272nM) and IL-6 (IC50=712nM) in LPS-stimulated human THP-1 macrophages and displays anti-inflammatory activity in animal models. Antileishmanial. HDAC6 deacetylates tubulin, HSP90 and the core histones (H2A, H2B, H3, H4). Histone deacetylases act via the formation of large multiprotein complexes. HDAC6 plays an important role in microtubule-dependent cell motility, transcriptional regulation, degradation of misfolded proteins and cell cycle and is involved in autophagy, inflammation, cancer and neurodegeneration.
Molecular Formula	C20H21N3O2
Alias Names	N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl] benzamide
Product Type	Chemicals & Biochemicals
Purity	>98%
Research area	Inflammation
Shipping Information	RT
Size	10 mg
Solubility	Soluble in DMSO.
Stability	Stable for at least 2 years after receipt when stored at -20°C.
Storage	-20°C, 4°C
Technical Specifications	Chemical. CAS: 1252003-15-8. Formula: C20H21N3O2. MW: 335.4. Cell permeable potent and selective class IIb histone deacetylase 6 (HDAC6) inhibitor (IC50=15nM, >1000-fold selective against other HDACs and 60-fold for HDAC8). Neuroprotective. Effectively prevents neuronal cell death (by >95% at 10µM) upon oxidative stress induction by HCA and selectively induces cellular alpha-tubulin, but not histone H4, hyperacetylation (2.5 to 5µM) in primary rat cortical neuron cultures. Improves cognition in Alzheimer's disease transgenic mice. Exhibits cardioprotective and anticancer chemotherapeutic activities. Reduces tumor growth and cell proliferation and induces cell cycle arrest in G1. Inhibits TNFalpha (IC50=272nM) and IL-6 (IC50=712nM) in LPS-stimulated human THP-1 macrophages and displays anti-inflammatory activity in animal models. Antileishmanial. HDAC6 deacetylates tubulin, HSP90 and the core histones (H2A, H2B, H3, H4). Histone deacetylases act via the formation of large multiprotein complexes. HDAC6 plays an important role in microtubule-dependent cell motility, transcriptional regulation, degradation of misfolded proteins and cell cycle and is involved in autophagy, inflammation, cancer and neurodegeneration.
Product Page Updated	2024-02-01T08:25:01.492Z

Documentation

Datasheet

MSDS

References

Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A: K.V. Butler, et al.; JACS 132, 10842 (2010) | Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells: E.F. de Zoeten, et al.; Mol. Cell Biol. 31, 2066 (2011) | Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells: J.H. Kalin, et al.; J. Med. Chem. 55, 639 (2012) | Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth: J.A. Bergman, et al.; J. Med. Chem. 55, 9891 (2012) | HDAC6 inhibition restores ciliary expression and decreases tumor growth: S.A. Gradilone, et al.; Cancer Res. 73, 2259 (2013) | Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects: S. Vishwakarma, et al.; Int. Immunopharmacol. 16, 72 (2013) | HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes: M. Noack, et al.; Glia 62, 535 (2014) | Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition: M.L. Selenica, et al.; Alzheimers Res. Ther. 6, 12 (2014) | Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice: L. Zhang, et al.; J. Alzheimers Dis. 41, 1193 (2014) | Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes: M.V. Kozlov, et al.; Biochem. 79, 637 (2014) | The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors: Q. Sodji, et al.; Bioorg. Med. Chem. Lett. 24, 4826 (2014) | Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation: K.V. Woan, et al.; Mol. Oncol. 9, 1447 (2015)

Shipping info

The delivery time for this item is approximately 5-8 business days. Read more